Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial

NCT07746271 is registered in ClinicalTrials.gov with The George Washington University Biostatistics Center as lead sponsor.

NCT NCT07746271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07746271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial
Lead sponsor
The George Washington University Biostatistics Center
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
April 30, 2030
Enrollment
4,120 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension in pregnancy, obstetrical complications